Faithward Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,595
Closed -$284K 301
2025
Q4
$284K Sell
3,595
-1,037
-22% -$82.1K 0.04% 269
2025
Q3
$382K Sell
4,632
-327
-7% -$25.7K 0.06% 219
2025
Q2
$399K Sell
4,959
-85
-2% -$6.56K 0.06% 188
2025
Q1
$405K Sell
5,044
-76
-1% -$6.32K 0.07% 176
2024
Q4
$419K Buy
5,120
+197
+4% +$16.4K 0.07% 169
2024
Q3
$406K Sell
4,923
-909
-16% -$67.9K 0.07% 192
2024
Q2
$409K Buy
5,832
+502
+9% +$35.8K 0.07% 180
2024
Q1
$395K Buy
5,330
+392
+8% +$27.3K 0.07% 179
2023
Q4
$325K Buy
4,938
+806
+20% +$50.4K 0.07% 142
2023
Q3
$250K Buy
+4,132
New +$257K 0.06% 150

Other funds holding MET

Faithward Advisors's MET Position: Q1 2026 in Review

Faithward Advisors sold out of MetLife (MET) in Q1 2026, closing a stake of 3,595 shares — an estimated $284K sold.

Faithward Advisors first reported a position in MET in Q3 2023 and held it in 10 quarters. The position peaked at $419K in Q4 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Faithward Advisors reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Faithward Advisors sold 3,595 MetLife shares in Q1 2026, an estimated $284K.
  • Faithward Advisors first reported a position in MetLife in Q3 2023 and held it in 10 quarters.
  • Faithward Advisors's MetLife position peaked at $419K in Q4 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.